Histamine in allergic inflammation and immune modulation

International Archives of Allergy and Immunology

Volumn 137, Issue 1, 2005, Pages 82-92

  Jutel, Marek ^a,b   Blaser, Kurt ^a   Akdis, Cezmi A ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Antihistamines; B cells; Dendritic cells; Histamine; T cells; Tolerance

Indexed keywords

ALPHA METHYLHISTAMINE; ANTIHISTAMINIC AGENT; BEE VENOM; BETAHISTINE; CETIRIZINE; CHLORPHENIRAMINE; CIMETIDINE; CINNARIZINE; CLEMASTINE; CLOBENPROPIT; CORTICOSTEROID; DESLORATADINE; DIMAPRIT; DOXEPIN; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; IMETIT; IMPROMIDINE; LORATADINE; MONTELUKAST; PROMETHAZINE; RANITIDINE; TERFENADINE; THIOPERAMIDE;

AIDS RELATED COMPLEX; ALLERGIC ENCEPHALOMYELITIS; ALLERGIC REACTION; ALLERGIC RHINITIS; ALLERGY; ASTHMA; CLINICAL TRIAL; DNA POLYMORPHISM; GASTRITIS; GENE DELETION; GENE DISRUPTION; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOTHERAPY; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY;

HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPERSENSITIVITY; INFLAMMATION; RECEPTORS, HISTAMINE; T-LYMPHOCYTES;

EID: 19444388127     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085108     Document Type: Review

References (108)

1. Dale HH, Laidlaw PP: Further observations on the action of β-imidazolylethylamine. J Physiol 1911;43:182-195.
2. Jutel M, Watanabe T, Akdis M, Blaser K, Akdis CA: Immune regulation by histamine. Curr Opin Immunol 2002;14:735-740.
3. Akdis CA, Blaser K: Histamine in the immune regulation of allergic inflammation. J Allergy Clin Immunol 2003;112:15-22.
4. Dy M, Schneider E: Histamine-cytokine connection in immunity and hematopoiesis. Cytokine Growth Factor Rev 2004;15:393-410.
5. MacGlashan D Jr: Histamine: A mediator of inflammation. J Allergy Clin Immunol 2003; 112(suppl 4):S53-S59.
6. Schneider E, Rolli-Derkinderen M, Arock M, Dy M: Trends in histamine research: New functions during immune responses and hematopoiesis. Trends Immunol 2002;23:255-263.
7. Haas H, Panula P: The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 2003;4:121-130.
8. 1 receptors in patients with Alzheimer's disease assessed by positron emission tomography. Neuroscience 2000;99:721-729.
9. Yokoyama H: The role of central histaminergic neuron system as an anticonvulsive mechanism in developing brain. Brain Dev 2001;23: 542-547.
10. 1-receptor gene. Hum Genet 1994;94:186-188.
11. Gantz I, Schaffer M, DelValle J, et al: Molecular cloning of a gene encoding the histamine H2 receptor. Proc Natl Acad Sci USA 1991;88: 429-433. Erratum Proc Natl Acad Sci USA 1991;88:5937.
12. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S: Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 2000;275:36781-36786.
13. Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K: Molecular cloning and characterization of a new human histamine receptor, HHR4. Biochem Biophys Res Commun 2000; 279:615-620.
14. Milligan G, Bond R, Lee M: Inverse agonism: Pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci 1995; 16:10-13.
15. 1-antihistamines: Inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 2002;32:489-498.
16. Paesen G, Adams P, Nuttall P, Stuart D: Tick histamine-binding proteins: Isolation, cloning, and three-dimensional structure. Mol Cell 1999;3:661-666.
17. Ash AS, Schild HO: Receptors mediating some actions of histamine. Br J Pharmacol 1966;27: 427-439.
18. Leurs R, Smit MJ, Timmerman H: Molecular pharmacological aspects of histamine receptors. Pharmacol Ther 1995;66:413-463.
19. 1 receptor. Clin Exp Allergy 1999;29:19-28.
20. Togias A: H1-receptors: Localization and role in airway physiology and in immune functions. J Allergy Clin Immunol 2003;112:S60-S68.
21. 1-receptor activation of nuclear factor-κB: Roles for G beta gamma and G alpha(q/11) subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 2001;60:1133-1142.
22. 4 mediates histamine induction of NF-κB and IL-8 in human bronchial epithelial cells. Am J Physiol 1998;274:L1030-L1039.
23. Hall IP: Pharmacogenetics of asthma. Eur Respir J 2000;15:449-451.
24. 1 receptors in mice: Behavioral and neurochemical characterization. Life Sci 1998;62:1607-1610.
25. Banu Y, Watanabe T: Augmentation of antigen receptor-mediated responses by histamine H1 receptor signaling. J Exp Med 1999;189: 673-682.
26. 2 receptor biology. Am J Physiol 1997; 273:G987-G996.
27. 3 receptor. Mol Pharmacol 1999;55:1101-1107.
28. 3-receptor modulation in rat lung and spleen. Clin Sci (Lond) 1994;87:151-163.
29. Zhu Y, Michalovich D, Wu H, Tan KB, Dytko GM, Mannan IJ, et al: Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 2001;59:434-441.
30. 4 receptor. Br J Pharmacol 2003;140:1117-1127.
31. 2 receptors control histamine-induced interleukin-16 release from human CD8+ T cells. J Pharmacol Exp Ther 2002;303:300-307.
32. 4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 2003;305:1212-1221.
33. 4 receptor on human eosinophils - Role in eosinophil chemotaxis. J Recept Signal Transduct Res 2002;22:431-448.
34. 4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 2004;309:404-413.
35. Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, Rauser L, Lee SP, Lynch KR, Roth BL, O'Dowd BF: Discovery of a novel member of the histamine receptor family. Mol Pharmacol 2001;59:427-433.
36. Endo Y: Simultaneous induction of histidine and ornithine decarboxylases and changes in their product amines following the injection of Escherichia coli lipopolysaccharide into mice. Biochem Pharmacol 1982;31:1643-1647.
37. Dy M, Lebel B, Kamoun P, Hamburger J: Histamine production during the anti-allograft response. Demonstration of a new lymphokine enhancing histamine synthesis. J Exp Med 1981;153:293-309.
38. Kubo Y, Nakano K: Regulation of histamine synthesis in mouse CD4+ and CD8+ T lymphocytes. Inflamm Res 1999;48:149-153.
39. 1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells. Semin Cancer Biol 2000;10:41-45.
40. Saxena SP, Brandes LJ, Becker AB, Simons KL, LaBella FS, Gerrard JM: Histamine is an intracellular messenger mediating platelet aggregation. Science 1989;243:1596-1599.
41. Szeberenyi JB, Pallinger E, Zsinko M, Pos Z, Rothe G, Orso E, Szeberenyi S, Schmitz G, Falus A, Laszlo V: Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation. Immunol Lett 2001;76:175-182.
42. Idzko M, la Sala A, Ferrari D, Panther E, Herouy Y, Dichmann S, Mockenhaupt M, Di Virgilio F, Girolomoni G, Norgauer J: Expression and function of histamine receptors in human monocyte-derived dendritic cells. J Allergy Clin Immunol 2002;109:839-846.
43. Gutzmer R, Langer K, Lisewski M, Mommert S, Rieckborn D, Kapp A, Werfel T: Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells. J Allergy Clin Immunol 2002;109:524-531.
44. Caron G, Delneste Y, Roelandts E, Duez C, Bonnefoy JY, Pestel J, Jeannin P: Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol 2001;167:3682-3686.
45. Caron G, Delneste Y, Roelandts E, Duez C, Herbault N, Magistrelli G, Bonnefoy JY, Pestel J, Jeannin P: Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J Immunol 2001; 166:6000-6006.
46. Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM: Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 2001;108:1865-1873.
47. 2 receptors. J Clin Invest 1998;102:1866-1873.
48. 2 receptors. J Immunol 1998;161:2586-2593.
49. Takahashi HK, Iwagaki H, Mori S, Yoshino T, Tanaka N, Nishibori M: Histamine inhibits lipopolysaccharide-induced interleukin (IL)-18 production in human monocytes. Clin Immunol 2004;112:30-34.
50. 2 receptors on human monocytes. Clin Immunol 2003;108: 274-281.
51. Morichika T, Takahashi HK, Iwagaki H, Yoshino T, Tamura R, Yokoyama M, Mori S, Akagi T, Nishibori M, Tanaka N: Histamine inhibits lipopolysaccharide- induced tumor necrosis factor-alpha production in an intercellular adhesion molecule-1- and B7.1-dependent manner. J Pharmacol Exp Ther 2003;304: 624-633.
52. 2 histamine receptors are absent on Langerhans cells and present on dermal dendritic cells. J Invest Dermatol 2003;121:1073-1079.
53. 2 receptors. Nature 2001;413:420-425.
54. 1. Science 2002;297:620-623.
55. Osna N, Elliott K, Khan MM: Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes. Int Immunopharmacol 2001;1:85-96.
56. Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K: Role of IL-10 in specific immunotherapy. J Clin Invest 1998;102:98-106.
57. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis C: IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003;33:1205-1214.
58. 1-mediated suppression of Th2 responses. FASEB J 2003;17:1089-1095.
59. Muller U, Hari Y, Berchtold E: Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy. J Allergy Clin Immunol 2001;107:81-86.
60. Jutel M, Zak-Nejmark T, Wrzyszcz M, Malolepszy J: Histamine receptor expression on peripheral blood CD4+ lymphocytes is influenced by ultrarush bee venom immunotherapy. Allergy 1997;52(suppl 37):88.
61. Gifford R, Schmidke J: Cimetidine-induced augmentation of human lymphocyte blastogenesis: Comparison with levamisole in mitogen stimulation. Surg Forum 1979;30:113-115.
62. 2 receptors ameliorates experimental allergic encephalomyelitis. Neuroreport 2002;13:1407-1410.
63. 2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist. J Clin Invest 1993;92:281-287.
64. Meretey K, Falus A, Taga T, Kishimoto T: Histamine influences the expression of the interleukin-6 receptor on human lymphoid, monocytoid and hepatoma cell lines. Agents Actions 1991;33:189-191.
65. Jeannin P, Delneste Y, Gosset P, Molet S, Lassalle P, Hamid Q, Tsicopoulos A, Tonnel AB: Histamine induces interleukin-8 secretion by endothelial cells. Blood 1994;84:2229-2233.
66. Bayram H, Devalia JL, Khair OA, Abdelaziz MM, Sapsford RJ, Czarlewski W, Campbell AM, Bousquet J, Davies RJ: Effect of loratadine on nitrogen dioxide-induced changes in electrical resistance and release of inflammatory mediators from cultured human bronchial epithelial cells. J Allergy Clin Immunol 1999; 104:93-99.
67. 1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa. J Allergy Clin Immunol 2001;107:123-128.
68. 1-receptor in cultured human endothelial cells. Biochem Biophys Res Commun 1987;148: 47-53.
69. Kubes P, Kanwar S: Histamine induces leukocyte rolling in post-capillary venules. A P-selectin-mediated event. J Immunol 1994;152: 3570-3577.
70. Yamaki K, Thorlacius H, Xie X, Lindbom L, Hedqvist P, Raud J: Characteristics of histamine-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery. Br J Pharmacol 1998;123:390-399.
71. Schaefer U, Schmitz V, Schneider A, Neugebauer E: Histamine induced homologous and heterologous regulation of histamine receptor subtype mRNA expression in cultured endothelial cells. Shock 1999;12:309-315.
72. Fadel R, Herpin-Richard N, Rihoux JP, Henocq E: Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo. Clin Allergy 1987;17:373-379.
73. Clark RA, Sandler JA, Gallin JI, Kaplan AP: Histamine modulation of eosinophil migration. J Immunol 1977;118:137-145.
74. 4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol 2004; 142:161-171.
75. Seligmann BE, Fletcher MP, Gallin JI: Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes. J Immunol 1983;130:1902-1909.
76. Yoneda K, Yamamoto T, Ueta E, Osaki T: Suppression by azelastine hydrochloride of NF-κB activation involved in generation of cytokines and nitric oxide. Jpn J Pharmacol 1997;73:145-153.
77. Ghosh AK, Hirasawa N, Ohtsu H, Watanabe T, Ohuchi K: Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J Exp Med 2002;195: 973-982.
78. Simons FER: Antihistamines; in Adkinson NF Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER (eds): Middleton's Allergy: Principles and Practice. Philadelphia, Mosby, 2003, pp 834-869.
79. 1 antihistamines on adhesion molecules: A possible rationale for long-term treatment. Clin Exp Allergy 1999;29(suppl 3):49-53.
80. 1 receptors. J Immunol 2001;166: 4083-4091.
81. Paolieri F, Battifora M, Riccio AM, et al: Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. Ann Allergy Asthma Immunol 1998;81: 601-607.
82. Casolaro V, Galeone D, et al: Human basophil/mast cell releasability. 5. Functional comparisons of cells obtained from peripheral blood, lung parenchyma, and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 1989;139: 1375-1382.
83. Liu MC, Bleecker ER, Lichtenstein LM, et al: Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 1990;142: 126-132.
84. Wenzel SE, Fowler AA, Schwartz LB: Activation of pulmonary mast cells by bronchoalveolar allergen challenge: In vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis 1988;137: 1002-1008.
85. Crimi E, Chiaramondia M, Milanese M, et al: Increase of mast cell numbers in mucosa after the late-phase asthmatic response to allergen. Am Rev Respir Dis 1991;144:1282-1286.
86. Pesci A, Foresi A, Bertorelli G, et al: Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects. Am Rev Respir Dis 1993;147:684-689.
87. Jarjour NN, Calhoun W, Schwartz LB, Busse WW: Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am Rev Respir Dis 1991;144:83-87.
88. Malick A, Grant JA: Antihistamines in the treatment of asthma. Allergy 1997;52:55-66.
89. Town GI, Holgate ST: Comparison of the effect of loratadine on the airway and skin responses to histamine, methacholine, and allergen in subjects with asthma. J Allergy Clin Immunol 1990;86:886-893.
90. 1-receptor antihistamines in the airways and skin of subjects with asthma. J Allergy Clin Immunol 1993;91:1005-1014.
91. MacFarlane PI, Heaf DP: Selective histamine blockade in childhood asthma: The effect of terfenadine on resting bronchial tone and exercise induced bronchoconstriction. Respir Med 1989;83:19-24.
92. Spector SL, Nicodemus CF, Corren J, et al: Comparison of the bronchodilatory effects of cetirizine, albuterol and both together versus placebo in patients with mild-to-moderate asthma. J Allergy Clin Immunol 1995;96:174-181.
93. Ghosh SK, De Vos C, McIlroy I, Patel KR: Effect of cetirizine on exercise induced asthma. Thorax 1991;46:242-244.
94. Aaronson DW: Evaluation of cetirizine in patients with allergic rhinitis and perennial asthma. Ann Allergy Asthma Immunol 1996;76: 440-446.
95. Corren J, Harris AG, Aaronson D, et al: Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 1998;101:792.
96. 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol 2003;130:307-313.
97. Reicin A, White R, Weinstein SF, et al: Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma. Arch Intern Med 2000;160:2481-2488.
98. Gelfand EW, Cui ZH, Takeda K, Kanehiro A, Joetham A: Fexofenadine modulates T-cell function, preventing allergen-induced airway inflammation and hyperresponsiveness. J Allergy Clin Immunol 2002;110:85-95.
99. Bryce PJ, Geha R, Oettgen HC: Desloratadine inhibits allergen-induced airway inflammation and bronchial hyperresponsiveness and alters T-cell responses in murine models of asthma. J Allergy Clin Immunol 2003;112: 149-158.
100. Warner JO: A double-blind, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. J Allergy Clin Immunol 2001;108:929-937.
101. Panettieri RA, Yadvish PA, Kelly AM, Rubinstein NA, Kotlikoff MI: Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression. Am J Physiol 1990;259:L365-L371.
102. Chand N, Eyre P: Classification and biological distribution of histamine receptor subtypes. Agents Actions 1975;5:277-295.
103. 2 receptor antagonist in normal and asthmatic subjects. Thorax 1980;35:428-434.
104. 2-receptor agonists on large and small airways in normal and asthmatic subjects. Br J Dis Chest 1987; 81:155-169.
105. 2-receptor- mediated function in patients with bronchial asthma and ragweed allergy. Chest 1986;89:491-496.
106. Field SK, Sutherland LR: Does medical anti-reflux therapy improve asthma in asthmatics with gastroesophageal reflux? A critical review of the literature. Chest 1998;114:275-283.
107. 3 receptors: Stimulation of IL-10 production. J Immunol 2000;164:2964-2970.
108. Benovic J: Novel β2-adrenergic receptor signaling pathways. J Allergy Clin Immunol 2002;110:S229-S235.